Furthermore, it suggests that CEMIP overexpression may be a novel target for therapy as studies in which tumor HA turnover is disrupted demonstrate tumor growth inhibition both in vitro and in vivo [13, 40]. This evidence concerns the gene CEMIP and neoplasm.